B. Lynne Parshall

2016

In 2016, B. Lynne Parshall earned a total compensation of $5.5M as Director, Chief Operating Officer at Ionis Pharmaceuticals, a 14% decrease compared to previous year.

Compensation breakdown

Bonus$801,761
Option Awards$3,143,869
Salary$712,676
Stock Awards$786,549
Other$29,773
Total$5,474,628

Parshall received $3.1M in option awards, accounting for 57% of the total pay in 2016.

Parshall also received $801.8K in bonus, $712.7K in salary, $786.5K in stock awards and $29.8K in other compensation.

Rankings

In 2016, B. Lynne Parshall's compensation ranked 1,394th out of 14,075 executives tracked by ExecPay. In other words, Parshall earned more than 90.1% of executives.

ClassificationRankingPercentile
All
1,394
out of 14,075
90th
Division
Manufacturing
469
out of 5,489
92nd
Major group
Chemicals And Allied Products
128
out of 1,895
93rd
Industry group
Drugs
87
out of 1,538
94th
Industry
Pharmaceutical Preparations
69
out of 1,176
94th
Source: SEC filing on April 10, 2017.

Parshall's colleagues

We found five more compensation records of executives who worked with B. Lynne Parshall at Ionis Pharmaceuticals in 2016.

2016

Stanley Crooke

Ionis Pharmaceuticals

Chief Executive Officer

2016

Brett Monia

Ionis Pharmaceuticals

Senior Vice President,

2016

Richard Geary

Ionis Pharmaceuticals

Senior Vice President, Development

2016

Patrick O'Neil

Ionis Pharmaceuticals

General Counsel

2016

Elizabeth Hougen

Ionis Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like